OPO accountability dossier

LifeSource (Upper Midwest Organ Procurement Organization)

MNOPCMS Tier 2

OPTN Region 7 — Minnesota, North Dakota, and South Dakota

CMS performance & status

Shown hatched/diagonal-line fill (Tier 2) on the CMS 2025 OPO Tier Status map based on 2023 performance data, distinctly different from its solid-blue Tier 1 neighbors; Tier 2 means below the top quartile but at/above the median on a measure.

This OPO is graded Tier 2 (2025 (data year 2023)) under the CMS Conditions for Coverage outcome measures. Tier 2 is above the median but below the top quartile; these OPOs must compete to retain their service area.

CMS QCOR 2025 Maps of OPO DSAs and Tier Status

Findings naming this OPO (2)

Investigation (1)

LifeSource OPO: $82.5M revenue, CEO compensation near $735,000

Upper Midwest Organ Procurement Organization (LifeSource)

Per the IRS Form 990 on ProPublica Nonprofit Explorer, the Upper Midwest Organ Procurement Organization (LifeSource) reported total revenue of $82,460,485 and total expenses of $75,927,629 for fiscal year 2024, with the Chief Executive Officer role compensated $734,946 plus $52,567 in other compensation. The figures illustrate the scale of nonprofit OPO budgets and executive pay funded substantially through Medicare reimbursement.

ProPublica Nonprofit Explorer — Upper Midwest Organ Procurement Organization (LifeSource) IRS Form 990 (EIN 36-3584029)

Money trail (1)

LifeSource (Upper Midwest OPO) reported ~$82-101M revenue in recent years; CEO comp up to ~$735K

Upper Midwest Organ Procurement Organization / LifeSource, EIN 36-3584029

Per IRS Form 990 data on ProPublica, the Upper Midwest Organ Procurement Organization (LifeSource) reported total revenue rising from $41.4M (2015) to a peak of $100.8M (2023), with $82.5M in 2024. The Chief Executive Officer role's compensation reached $734,946 (2024).

Upper Midwest Organ Procurement Organization (LifeSource), IRS Form 990 via ProPublica (EIN 36-3584029)


Every item is institution-level public record, source-linked; no patient, donor, or family is named. A Tier or finding here repeats the government's own assessment of an organization holding a public monopoly. Back to OrganWatch.